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To elucidate the potential role of adhesion molecules in the 
pathogenesis of rheumatoid arthritis (RA), we stained specimens of 
synovial tissue from patients with RA and osteoarthritis (OA) with 
monoclonal antibodies against adhesion molecules using an 
immunohistochemical method. Positive staining with anti-ICAM-1 
monoclonal antibody was detected on the synovial lining cells, the 
sublining cells and the capillary endothelial cells in the synovium from 
patients with RA, and, to a lesser degree, in that from patients with 
OA. The capillary endothelial cells from patients with RA intensively
expressed　 both　 ELAM-1　 and　 VLA-5α 　molecules,　 in　contrast　 to　that
from OA patients. The intensity of both ICAM-1 and ELAM-1 on the 
capillary endothelial cells in RA synovium was comparable to disease 
activity and to the degree of synovial proliferation. A high density of
expression　 of　LFA-1α 　,　VLA-4α 　and　 VLA-5α 　was　 observed　 on　 the
mononuclear cells that infiltrated the RA synovium, especially in the 
lesions with aggregated mononuclear cells. The findings clearly 
demonstrated an up-regulation of the expression of adhesion 
molecules on synovial cells, capillary endothelial cells and infiltrated 
mononuclear cells in the synovial tissues of patients with RA. This 
enhanced expression of adhesion molecules may play an important 
role in the migration of mononuclear cells into the synovial tissues and 
thus perpetuate the inflammatory response in these tissues.
Key Words: rheumatoid arthritis, osteoarthritis, adhesion molecule, 
synovium.
Introduction 
Rheumatoid arthritis (RA) is associated with immune dys-
functions which contribute to its pathogenesis (1). The 
synovial membrane contains a dense infiltration of mono-
nuclear cells, predominantly T cells (2, 3) that contribute to 
the intraarticular inflammation via the production of cyto-
kine and the promotion of B cell hyperactivity. The result is 
an excess production of immunoglobulins and rheumatoid 
factors (4, 5). Under current investigation is the mechanism
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by which the T cells are continually recruited into the 
synovium to set up inflammatory lesions which eventually 
lead to the degradation of cartilage and bone. 
 Adhesion molecules play a fundamental role in diverse 
immunological functions, especially the presentation of 
antigen, the recognition of target cells by effector cells, and 
the migration and retention of mononuclear cells (6, 7). 
They may also mediate signal transduction, leading to the 
activation or proliferation of cells (8, 9). The molecules 
involved in such interactions consist of four superfamilies 
classified according to their molecular characteristics: the 
integrin family, the immunoglobulin (Ig) supergene family, 
the selectin family, and the H-CAM family (CD44). The 
adhesion-dependent interactions of lymphocytes in pro-
cesses that are dependent on, or-independent of, antigen, 
are mediated via an interaction of the integrin lymphocyte 
function-associated antigen 1 (LFA-1) with the Ig super-
gene family intercellular adhesion molecule 1 (ICAM-1) 
(10, 11). Those include T-cell interactions with antigen-
presenting cells, cytotoxity by T-lymphocytes, and binding 
of lymphocytes to the endothelium (12, 13). A second 
adhesion pathway via the binding of very late antigen 4 
(VLA-4) to vascular cell adhesion molecule 1 (VCAM-1) 
and fibronectin (CSI) has been defined (14, 15). These 
molecules belong to the integrin, the Ig supergene family 
and the extracellular matrix, respectively, and mediate the 
adhesion of lymphocytes to the endothelium and a 
antigen-presenting cells (13, 14). A pathway via the bind-
ing of VLA-5 to fibronectin has also been described (12). 
A third pathway via sialyl Lex and sialyl Lea with 
endothelial-leukocyte adhesion molecule 1 (ELAM-1), 
which belong to the selectin family, can mediate the adhe-
sion of neutrophils and monocytes, and of lymphocytes to 
the endothelium (16-20). 
 We investigated the expression of adhesion molecules on 
synovial tissues from patients with RA and the correlation 
of this expression with the presence of general or of local 
inflammatory disease. These findings were compared with 
those in specimens obtained from patients with OA.
Materials and Methods 
Patients. 
Specimens of inflamed synovial membrane were obtained 
from patients who were undergoing total knee arthroplasty 
or synovectomy. We studied 10 patients (2 men and 8 
women, mean age; 54.0 ± 11.6 ( ± SD), range; 36-72 
years) who met the American College of Rheumatology 
criteria RA (21). Table 1 shows their clinical character-
istics. At the time of study, all patients were taking non-
steroidal anti-inflammatory drugs (NSAIDs). Four of them 
were also taking slow-acting anti-rheumatic drugs 
(SAARDs) including gold sodium thiomalate, methotrexate 
and D-penicillamine. In addition, 7 patients with RA were 
receiving prednisolone at a dose of less than 10mg daily. 
We also studied 4 patients with OA (1 man and 3 women, 
mean age; 58.4 ± 8.7 ( ± SD), range; 51-70 years). 
Specimens of normal synovial tissue were also obtained 
from 3 patients who were undergoing corrective surgery 
for joint trauma. Patients with RA were divided into 2 
groups according to their inflammatory activity as follows 
(22): (a) duration of morning stiffness >_ 45min; (b) ery-
throcyte sedimentation rate >_ 28min/hour; and (c) the 
number of tender joints >_ 9; (d) the number of swollen 
joints >_ 6. Five patients fulfilled at least three of these four 
criteria and were classified as the active disease group, 
while 5 patients were classified as the inactive disease 
group. In addition, by arthroscopic examination, we graded 
the local inflammatory activity as follows: grade 1: mild 
synovial proliferation; grade 2: moderate synovial prolif-
eration; and grade 3: severe synovial proliferation. The 
same rheumatologist evaluated the grades of the local 
inflammatory activity in all cases.
I m m uno h is toc he m is try. 
The synovia from 10 RA patients and 4 OA patients and 3 
normal synovia were stained by an immunohistochemical 
technique described elsewhere (23). Fresh synovial sec-
tions were fixed in 4% paraformaldehyde solution (Wako 
Co., Tokyo, Japan) for 8 hours at 4°C , then washed with 
phosphate-buffered saline solution (PBS) for 15 hours, or 
with 30% saccharose (Wako Co., Tokyo, Japan) in PBS for 
30 minutes. The fixed tissues were embedded in 0. C. T. 
compound and quickly frozen on glass slide coated with 
albumin. Sections at 6 ,u m thick were mounted on the 
coated slides and stained by the labeled-streptavidin biotin 
method (Histofine staining kit. Nichirei Co., Tokyo, Japan). 
Briefly, endogenous peroxidase was inactivated by emerg-
ing the section in a 3% H202 solution. Sections were next 
incubated with non-immune rabbit IgG, then with mouse 
monoclonal antibodies directed against adhesion molecules 
in a humidified chamber for 1 hour at room temperature. 
The monoclonal antibodies used in this experiment are 
characterized in Table 2. Sections were treated with bioti-
nylated rabbit anti-mouse IgG for 30 miniutes. After being 
washed, they were incubated with peroxidase-conjugated 
streptavidin. Color was developed using 3.3'-diamino-
benzidine (Sigma Chemical Co., St. Louis, MO) and H2O2. 
Slides were counterstained with hematoxylin. Anti-factor 
VIII monoclonal antibody was used for staining as a 
marker of vascular endothelial cells. Control sections were 
treated with anti-insulin antibody instead of specific mono-
clonal antibody. The intensity of antigen expression was 
tentatively categorized as: (-): negative staining, (± ): faint 
staining, (+): positive staining, and (++): very bright stain-
ing.
Table 1. Clinical characteristics of 10 patients with rheumatoid arthritis
                            Morning Tender Swollen ESR CRP Drug therapy  Case Age Sex Class Stage stiffness joints joints (mm/h) (mg/dl)                              (minutes) Current Previous 
  1 65 F 3 3 120 9 1 40 2.1 PSL (2.5mg/d) Gold. PSL 
  2 61 F 3 3 240 10 3 54 3.2 PSL (5.Omg/d) PSL. MTX 
  3 36 M 2 2 0 2 0 36 2.0 PSL (10.Omg/d) PSL 
  4 61 F 2 3 360 9 5 92 9.0 PSL (5.Omg/d) Gold. D-P. CCA Bucil 
  5 46 F 2 4 0 1 1 11 0.0 Gold 
  6 59 F 2 1 90 12 11 23 4.3 PSL (5.Omg/d) PSL 
  7 59 F 3 4 5 12 10 26 3.8 PSL (2.5mg/d) PSL. MTX 
                                                      MTX 
  8 72 F 3 2 240 14 5 107 10.5 PSL (2.5mg/d) 
  9 40 M 2 3 0 3 3 58 3.1 MTX Gold. D-P. Bucil. PSL 
  10 41 F 2 3 60 4 5 34 0.9 D-P D-P.CCA. Bucil. PSL 
ESR: erythrocyte sedimentation rate CRP: C-reactive protein PSL: prednisolone MTX: methotrexate 
D-P: D-penicillamine CCA: lobenzarit disodium Bucil: bucillamine
Table 2. Murine monoclonal antibodies
    Clone Specificity Dilution Source 
    2002 Factor VIII 1:2 Nichirei Co., Tokyo Japan 
    84H10 ICAM-1 0.5, tg/ml Immunotech, Marseiles, France 
    25, 3. 1 LFA-1 a 1,u g/ml Immunotech 
    BBA-1 ELAM-1 5,ug/ml British Biotechnology, Oxon, UK 
    I G11 VCAM-1 5,u g/ml Immunotech 
    HP2.1 VLA-4 a I ,u g/ml Immunotech 
    SAMI VLA-5a 1,ug/ml Immunotech 
    2006 Insulin 1:2 Nichirei Co., 
ICAM-1 : intercellular adhesion molecule 1, LFA-1 a : lymphocyte function-associated antigen 1 a , 
ELAM-1 : endothelial-leukocyte adhesion molecule 1, VCAM-1 : vascular cell adhesion molecule 1, 
VLA-4a : very late antigen 4a , VLA-5a : very late antigen 5a ,
Results 
Expression of ICAM-1 and LFA-1 on synovial tissues from 
patients with RA and OA. 
Table 3 summerizes the degrees of ICAM-1 and LFA-1 
expression in the synovial tissues from patients with RA 
and OA that were stained with anti-ICAM-1 and anti-
LFA-1, and concomitantly with anti-factor VIII mono-
clonal antibodies. No staining was observed when anti-
insulin monoclonal antibody was used as control. As shown 
in Fig. IA and 2A, positive staining for factor VIII was
found on the capillary endothelial cells in the sublining 
layer of synovium from both the RA and OA patients. We 
detected the expression of ICAM-1 on the capillary endo-
thelial cells in the sublining layer of RA synovium (Fig. 
113), and to a lesser extent, in the sublining layer of OA 
synovium (Fig. 2B). In patients with RA, the intensity of 
ICAM-1 expression on vascular endothelial cells were 
correlated with generalized disease activity and the grade 
of synovial proliferation. ICAM-1 positive staining were 
also observed on the infiltrated mononuclear cells in the 
sublining layer of RA patients (Fig. 1B) but not on that OA 
patients (Fig. 2B). RA and OA patients each showed an
Table 3. Expression of ICAM-1 and LFA-la on synovium from patients with rheumatoid arthritis and osteoarthritis, and healthy controls
   Disease/Patients Staining for ICAM-1* Staining for LFA-Ia* Arthroscopy findings" 
                LC SLC EC MNC LC SLC EC MNC 
 Rheumatoid arthritis 
           Case 1 ++ + ++ + - - - + +++ 
               2 ++ + ++ + - - - + ++
                3 ++ + + + - - - + +
               4 ++ + + +- - - - + +++
                5 ++ + + + - - + +-
               6 ++ + ++ + - - - + +++
               7 ++ + + + - - - + +
                8 ++ + ++ + - - - + ++ 
               9 ++ + ++ + - + +
               10 ++ + + +- - - - + +
 Osteoarthritis 
           Case 1 + + + - - - - + 
2 ++ + ++ - + +-
               3 + + + - - + 
4 + + + - + 
Healthy subjects 
           Case 1 - - - - - - - - -
                2 - - - - - - - - -
                3 - - - - - - - - -
LC : synovial lining cells, SLC : synovial sublining cells, 
EC : capillary endothelial cells, MNC : mononuclear cells 
       negative staining, (+-): faint staining,(+): positive staining, 
  (++) : very bright staining 
        no synovial proliferation, (+-) : faint synovial proliferation, 
  (+) : mild synovial proliferation, (++): moderate synovial proliferation, 
  (+++): severe synovial proliferation
enhanced expression of ICAM-1 on the synovial lining 
cells and synovial sublining cells The intensity of ICAM-1 
expression on these synovial cells was greater in RA with a 
trend toward lesser amounts in OA (Table 3) An up-
regulated expression of LFA-1 was indicated on the infil-
trated mononuclear cells in synovial sections from patients 
with RA as well as from OA (Fig 1 C and 2C, Table 3) 
LFA-1 positive mononuclear cells infiltrated the areas of 
aggregated mononuclear cells, especially around the 
ICAM-1-expressed vessels No staining with anti-ICAM-1 
and anti-LFA-1 monoclonal antibodies was observed in the 
sections of normal synovium 
Expression of ELAM-1, VLA-4 and VLA-S on synovial 
tissue from RA and OA patients 
Data on immunostaining of synovial tissues from patients 
with RA and OA are summarized in Table 4 Intense 
staining of ELAM-1 was detected on the capillary endothe-
lial cells in sections of synovia from patients with RA (Fig
ID, Table 4) Expression of ELAM-1 on the capillary 
endothelial cells in the synovia from the patients with 
active RA was more extensive and intense than on those 
from the patients with inactive RA In addition, an up-
regulated expression of ELAM-1 was indicated on the 
endothelial cells in the synovial sections obtained from RA 
patients with moderate or severe local inflammatory activ-
ity In contrast, the capilary endothelial cells of patinets 
with OA express no staining or stained only faintly for 
ELAM-I expression (Fig 2D) Intense staining of VLA-4 
was found on the infiltrated mononuclear cells in synovial 
sections from both patients with RA and OA (Fig lE and 
2E) VLA-4 positive mononuclear cells were especially 
evident in the areas of cell aggregation VLA-4 positive 
staining on the synovial sublining cells was also found in 
the RA synovium (Fig IF), but not in the OA synovium 
(Table 4) In synovial sectios from patients with RA, 
staining with anti-VLA-5a monoclonal antibody was 
observed on the synovial lining cells, sublining cells, capil-
lary endothelial cells and infiltrated mononuclear cells (Fig
Fig. 1. (to be continued)
Fig. 1. Expression of factor VIII, ICAM 1, LFA 1, ELAM-1, VLA-4 and VLA 5 on synovial tissues from patients with RA Synovial 
specimens were stained with the following monoclonal antibodies by an immunoperoxidase technique 
(A) anti factor VIII monoclonal antibody (X 100) (B) anti-ICAM 1 monoclonal antibody (X 100) 
(C) anti LFA 1 a monoclonal antibody (X100) (D) anti-ELAM-l monoclonal antibody (X100) 
(E) anti VLA 4a monoclonal antibody (X100) (F) anti VLA 4a monoclonal antibody (X400) 
(G) anti VLA-5 a monoclonal antibody (X100) (H) anti VLA 5 a monoclonal antibody (X l00)
Fig. 2. (to be continued)
Fig. 2. Expression of adhesion molecules on synovial tissues from patients with OA Synovial sections were stained with the following 
monoclonal antibodies as used Fig 1 
(A) anti factor VIII monoclonal antibody (X100) (B) anti-ICAM 1 monoclonal antibody (X100) 
(C) anti LFA-1 a monoclonal antibody (X100) (D) anti-ELAM-1 monoclonal antibody (X100) 
(E) anti-VLA-4a monoclonal antibody (X100) (F) anti-VLA 5a monoclonal antibody (X400)
1 G and I H) The intensity of VLA-5 a expression on 
capillary endothelial cells in RA synovium paralled the 
severity of local inflammatory activity (Table 4) The lining 
cells in the OA synovium reacted with anti-VLA-5 a 
monoclonal antibody (Fig 2F) There was no increased 
expression of VLA-5 on synovial subliming cells, capillary 
endothelial cells or infiltrated mononuclear cells of syn-
ovium from patients with OA (Fig 2F) No staining with 
anti-ELAM-l, anti-VLA-4a anti-VLA-5a monoclonal 
antibodies was observed in the normal synovium
Table 4. Expression of ELAM-1, VLA-4a and VLA-5a on synovium from patients with rheumatoid arthritis and osteoarthritis, 
       and healthy controls
  Disease/Patients Staining for ELAM-1' Staining for VLA-4a' Staining for VLA-5a. Arthroscopy 
               LC SLC EC MNC LC SLC EC MNC LC SLC EC MNC findings" 
Rheumatoid arthritis 
         Case 1 - - + - - + - ++ ++ ++ ++ + +++ 
              2 - - + - - + - ++ ++ + ++ + ++ 
              3 - - + - - + - ++ ++ + + + +
              4 - - + - - + - ++ ++ + ++ + +++
              5 - - +- - - + - ++ ++ + ++ + +-
              6 - - + - - + - ++ ++ + ++ +- +++
              7 - - + - - + - +- ++ + +- + +
              8 - - + - - + - ++ + + ++ +- ++ 
              9 - - + - - + - + ++ +- +- +- +
              10 - - +- - - + - + + - +- - +
Osteoarthritis 
          Case 1 - - +- - - + - + ++ +- - +- 
2 - - +- - - - - +- + - - - 
3 - - - - - + + - - - 
4 - - +- - - - - + ++ +- +- - 
Healthy subjects 
          Case 1 - - - - - - - - - - - - -
              2 - - - - - - - - -
              3 - - - - - - - - - - - - -
LC: synovial lining cells, SLC: synovial sublining cells, EC: capillary enbothelial cells, MNC: mononuclear cells 
  (-) : negative staining, (+-): faint staining, (+): positive staining, (++): very bright staining 
       no synovial proliferation, (+-): faint synovial proliferation, (+): mild synovial proliferation 
  (++) : moderate synovial proliferation, (+++): severe synovial proliferation
Discussion 
In the synovial micro-environment, multiple cell-cell and 
cell-extracellular matrix interactions are influenced by the 
local release of soluble mediators. The attachment of T 
cells to endothelial cells leads to their subsequent migration 
between the endothelial cells into the surrounding tissue, 
and is critically important. Studies suggest that at least 
three molecular pathways of adhesion mediate the binding 
of T-cells to human umbilical vein endothelial cells in 
culture (HUVEC), LFA-1 integrin mediates the adhesion of 
lymphocytes to HUVEC by binding its ligand, ICAM-1 
(10, 24, 25). Various studies suggest that the adhesion of 
T-cells to HUVEC is also mediated by an LFA-1-inde-
pendent mechanism, as has been confirmed by the identi-
fication of two LFA-1-independent pathways: one pathway 
is mediated by the inducible vascular cell adhesion mole-
cule 1 (VCAM-1); second is the lymphocyte molecule that 
binds VCAM-1 has been identified as of VLA-4 integrin, 
which also mediates adhesion to the connecting segment 1 
(CS-1) of fibronectin (26, 27); third is the inducible endo-
thelial cell surface protein ELAM-1, which also mediates 
the adheion of granulocytes to activated HUVEC (16-19). 
The ELAM-1 pathway is now thought to be important in 
the initial attachment of memory T cells to the inflamed 
endothelium and in the preferential migration of memory T 
cells into tissues and inflammatory sites (14, 20). 
 We have shown that synovial tissues from patients with
RA demonstrate the intensive expression of ICAM-1 and 
ELAM-1 on vascular endothelial cells in the synovial 
sublining layer. This finding agrees with a previous report 
showing that ELAM-1 has endothelial reactivity, being 
present mainly on the venules and capillaries, and staining 
more blood vessels in RA than in OA (28). VCAM-1 is 
present on the synovial tissue endothelial cells of venules, 
capillaries, and arterioles in both RA and OA (28, 29). Like 
ELAM-1, VCAM-1 was present more often on the vascular 
endothelial cells in RA than OA tissues (28, 29). 
 There is increasing evidence that the adhesion of T-cell 
to endothelial cells can be regulated in several ways. First, 
the activation of endothelial cells can be regulated by 
inflammatory cytokines such as IL-1,6 and TNF-a , re-
sulting in a rapid increase in the expression of ICAM-1 and 
the induction of the expression of both VCAM-1 and 
ELAM-1 on the surface of endothelial cells (30, 31). 
Because IL-1 and TNF-a are found in both the synovial 
fluid and tissues of patients with RA and, to a lesser extent, 
in those with OA (32, 33). They may induce the expression 
of adhesion molecules on vascular endothelial cells. Thus, 
adhesion molecules are expressed mainly on endothelial 
cells in the synovial tissues of patients with RA and, to a 
lesser extent, of those with OA. 
 Our study showed that infiltrated mononuclear cells had 
an enhanced expression of LFA-1 a , VLA-4a and VLA-
5a molecules. Synovium from the OA patients contained a 
lower expression of VLA-4a and VLA-5a molecules
than did the RA synovium. The infiltrated mononuclear 
cells that intensively expressed these adhesion molecules 
were present around the vascular endothelial cells that 
expressed the ICAM-1 and ELAM-1. We previously dem-
onstrated that the T cells that infiltrate the synovium of RA 
patients are dominantly memory T cells which bear the 
markers of CD45RO and CD29 (34). Circulating memory 
T cells reportedly have an increased expression of adhesion 
molecules, and have greater ability to adhere to HUVEC, 
than the naive cells that bear CD45RA molecules (35, 36). 
Furthermore, mononuclear cells from the RA synovium 
show activated markers such as HLA-DR and CD26, and 
an enhanced expression of adhesion molecules including 
LFA-1 a, VLA-4a and VLA-5a as compared with the 
circulating mononuclear cells (37). These observations 
indicate that the circulating activated T cells, especially the 
memory T cells had an increased expression of adhesion 
molecules, resulting in the migration of T-cells through the 
endothelium into the site of joint inflammation. 
  We found that the intensity of the expression of adhesion 
molecule was paralled generalized disease activity and the 
localized proliferation of synovial cells. Walters et al (38) 
and Rooney et al (39) described a decrease in the number 
of lymphocyte in the synovial membrane associated with 
an improvement in the variables that reflected disease 
activity during treatment with slow-acting anti-rheumatic 
drugs (SAARD). The improvement in RA during gold 
treatment is accompanied by a reduction in the numder of 
synovial blood vessels that express ELAM-1 (40). We 
previously demonstrated that lobenzarit disodium and bu-
cillamine inhibit the adhesion of T cell to HUVEC in vitro 
(41, 42). The change in expression of adhesion molecules 
may be secondary to a decreased production of such in-
flammatory cytokines as IL-1$ and TNF- a , or may in-
stead be a direct effect on the vascular endothelial cells in 
the inflamed joint. 
  Positive staining with-anti-ICAM-1 monoclonal antibody 
was detected on the lining cells and the sublining cells in 
the synovium from RA patients and, to a lesser extent, in 
the synovium from OA patients. Synovial cells from these 
patients intensely express VCAM-1 as well as ICAM-1 
molecules (28, 29). The expression of both molecules on 
the fibroblast like synovial cells is induced by the exposure 
to proinflammatory cytokines including IL-1 8, TNF- a 
and IFN- y (29). The cytokines are synergistic in this re-
spect. We (43) and other investigators (44) demonstrated 
previously that the stimulation of synovial cells with cyto-
kine also increases the binding of circulating T cells. 
Furthermore, the memory T cells bearing CD45RO and 
CD29 are more adhesive to the IL-1$-stimulated synovial 
cells than the naive T cells bearing CD45RA. The mean 
fluorescent intensities of LFA-1 and CD2 molecules on 
adherent T cell population are significantly exceeded those 
on nonadherent T-cell population. These findings agree 
with those showing that the memory T-cell population have
an enhanced expression of such adhesion molecules as 
LFA-1, CD2, VLA-4 and VLA-5 as compared with naive 
T-cell population (12). The adhesion of T cells to cytokine-
activated synovial cells is partially inhibited by anti-LFA-1, 
anti-ICAM-1, anti-VCAM-1, anti-VLA-4 and CS-I peptide 
from alternatively spliced fibronectin, another VLA-4 li-
gand (29, 43, 44). These results suggest that the binding of 
T cells to cytokine-activated synovial cells is mediated via 
several pathways such as ICAM-1/1FA-1, VCAM-l/ 
VLA-4, and fibronectin/VLA-4. 
  We also demonstrated that VLA-4a was expressed on 
the majority of infiltrated mononuclear cells in RA syn-
ovium, and to a lesser degree, on the synovial sublining 
cells. In contrast to VLA-4a, the VLA-5 positive staining 
was present diffusely on the synovial lining cells, sublining 
cells, vascular endothelial cells and infiltrated mononuclear 
cells. It has been reported that VLA-5a is expressed on the 
synovial cells, vascular endothelial cells and infiltrated 
mononuclear cells (45), which suggests that the VLA 
expressed on these cells may interact with the extracellular 
matrix fibronectin. However, the precise role of VLA-5 
expression on synovial cells nad endothelial cells remains 
to be clarified. 
  In summary, vascular endothelial cells in the sublining 
layer from RA synovium expressed ICAM-1 and ELAM-1. 
These expression of these adhesion molecules appeared to 
be correlated with disease activity and synovial prolif-
eration. The infiltrated mononuclear cells had an increased 
expression of LFA-1, VLA-4, VLA-5 and ICAM-1. Syn-
ovial lining cells and sublining cells were stained by anti-
ICAM-1 and anti-VLA-5 monoclonal antibodies. Adhesion 
molecules thus appear to play an important role in the 
migration of lymphocytes into synovial tissues, and in the 
interaction between lymphocytes and synovial cells. This 
may result in the activations and stimulation of inflam-
matory response in the RA synovium.
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